Jose Miguel J.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
Data & Insights
Has run more than one trial at 6 of 59 partner sites.
Specializations
Thoracic Oncology
Clinical research activity is strongly centered on non-small cell lung cancer and small cell lung cancer, with attention to advanced, metastatic, resectable, and biomarker-defined disease. The portfolio also extends to related thoracic malignancies and treatment-resistant lung cancer settings.
- Advanced and metastatic NSCLC
- Small cell lung cancer and extensive-stage SCLC
- EGFR-, ALK-, ROS1-, and KRAS G12C-driven disease
- Resectable and locally advanced lung cancer
Work in this area also includes lung cancer with brain metastasis and non-squamous histologies, reflecting involvement in precision-oriented oncology care.
Breast, Gastrointestinal, and Genitourinary Cancers
Another major focus is solid tumor oncology, especially breast cancer, colorectal cancer, gastric cancer, pancreatic cancer, and biliary tract cancer. The research landscape also includes prostate cancer, bladder cancer, ovarian cancer, and endometrial cancer.
- Breast cancer across early and metastatic settings
- Colorectal cancer and gastroesophageal adenocarcinoma
- Pancreatic adenocarcinoma and biliary tract cancer
- Urothelial, prostate, and ovarian malignancies
These activities indicate sustained involvement in treatment strategies for both common and high-risk solid tumors.
Melanoma, Head and Neck, and Other Solid Tumors
The investigator is also involved in cancers where immunotherapy and targeted approaches are central, including melanoma, head and neck squamous cell carcinoma, esophageal cancer, and cutaneous squamous cell carcinoma. Research extends to advanced solid tumors and neuroendocrine carcinoma.
- Melanoma in resectable, unresectable, and metastatic settings
- Head and neck squamous cell carcinoma
- Esophageal squamous cell carcinoma
- Advanced solid tumors
This area reflects engagement with tumor types where immune-based and biomarker-selected therapies are important therapeutic domains.
Autoimmune and Inflammatory Diseases
The clinical research profile includes immune-mediated disorders such as rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, and Crohn's disease. Additional interest is seen in myasthenia gravis, multiple sclerosis, and bullous pemphigoid.
- Rheumatoid arthritis and psoriatic arthritis
- Systemic lupus erythematosus and systemic sclerosis
- Inflammatory bowel disease, including Crohn's disease
- Myasthenia gravis and multiple sclerosis
In this domain, the investigator is active across chronic autoimmune conditions requiring targeted immunomodulatory therapy.
Neurology, Hematology, and Cardiometabolic Disorders
Additional research interests span epilepsy, amyotrophic lateral sclerosis, Parkinson's disease, and migraine, alongside hematologic conditions such as hemophilia, multiple myeloma, acute myeloid leukemia, and myelodysplastic syndromes. The portfolio also includes cardiovascular disease, type 2 diabetes, obesity, and hypercholesterolemia.
- Epilepsy, ALS, and Parkinson's disease
- Hemophilia and other bleeding disorders
- Myeloma, leukemia, and myelodysplastic syndromes
- Cardiometabolic disease, including type 2 diabetes and obesity
These interests show participation in therapeutic areas that include both chronic disease management and highly specialized rare-disease care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.